iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
181.02
+5.35 (3.05%)
At close: Oct 16, 2025, 4:00 PM EDT
181.02
0.00 (0.00%)
After-hours: Oct 16, 2025, 4:00 PM EDT
iRhythm Technologies Employees
iRhythm Technologies had 2,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$328,614
Profits / Employee
-$46,217
Market Cap
5.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,000 | 0 | - |
| Dec 31, 2023 | 2,000 | 207 | 11.54% |
| Dec 31, 2022 | 1,793 | 93 | 5.47% |
| Dec 31, 2021 | 1,700 | 543 | 46.93% |
| Dec 31, 2020 | 1,157 | 160 | 16.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRTC News
- 4 weeks ago - IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC - GlobeNewsWire
- 5 weeks ago - IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service - GlobeNewsWire
- 2 months ago - iRhythm Technologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Investor Short Report Flags Steep Downside Risk For iRhythm Technologies - Benzinga
- 2 months ago - AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority - GlobeNewsWire
- 2 months ago - iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - iRhythm Technologies Announces Second Quarter 2025 Financial Results - GlobeNewsWire